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GenipinMitochondrial uncoupling protein 2 (UCP2) can moderate oxidative stress by favoring the inﬂux of protons
into the mitochondrial matrix, thus reducing electron leakage from respiratory chain and mitochondrial su-
peroxide production. Here, we demonstrate that UCP2 inhibition by genipin or UCP2 siRNA strongly increases
reactive oxygen species (ROS) production inhibiting pancreatic adenocarcinoma cell growth. We also show
that UCP2 inhibition triggers ROS-dependent nuclear translocation of the glycolytic enzyme glyceraldehyde
3-phosphate dehydrogenase (GAPDH), formation of autophagosomes, and the expression of the autophagy
marker LC3-II. Consistently, UCP2 over-expression signiﬁcantly reduces basal autophagy conﬁrming the
anti-autophagic role of UCP2. Furthermore, we demonstrate that autophagy induced by UCP2 inhibition deter-
mines a ROS-dependent cell death, as indicated by the apoptosis decrease in the presence of the autophagy inhib-
itors chloroquine (CQ) or 3-methyladenine (3-MA), or the radical scavenger NAC. Intriguingly, the autophagy
induced by genipin is able to potentiate the autophagic cell death triggered by gemcitabine, the standard chemo-
therapeutic drug for pancreatic adenocarcinoma, supporting the development of an anti-cancer therapy based on
UCP2 inhibition associated to standard chemotherapy. Our results demonstrate for theﬁrst time thatUCP2plays a
role in autophagy regulation bringing new insights into mitochondrial uncoupling protein ﬁeld.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
The uncoupling proteins (UCPs) belong to the mitochondrial
anion transporter superfamily located in the inner mitochondrial
membrane [1]. In mammals, ﬁve different UCP homologues have
been described, UCP 1–5, which have different levels of identity and
different tissue distribution [2–4]. Several studies have shown that
the antioxidant UCP2 is broadly over-expressed in cancer cells [5,6],
supporting this feature as an adaptive mechanism developed by tu-
mors to maintain homeostasis of reactive oxygen species (ROS)
[6,7]. The “uncoupling to survive” hypothesis conceives that a portion
of the mitochondrial proton gradient used to drive ATP synthesis is
“leaked” back into the matrix through UCP2 to render the electron
ﬂow through the respiratory complexes more efﬁcient and to de-
crease mitochondrial superoxide emission [1,8]. Negre-Salvayre et
al. ﬁrst suggested a role for the uncoupling proteins in curtailing mi-
tochondrial ROS production demonstrating that inhibition of UCP2
with GDP resulted in a sharp rise in H2O2 [9]. This evidence was
later supported by our group among others demonstrating that
UCP2 inhibition by siRNA or by the speciﬁc inhibitor genipin increasesction Sciences, Section of Bio-
7134 Verona, Italy. Tel.: +39
adelli).
l rights reserved.mitochondrial superoxide ion production in cancer cells [10], while
UCP2 over-expression diminishes ROS production [11]. In addition,
it was demonstrated that UCP2 plays a key role in the acquisition of
drug-resistant cancer phenotypes protecting cells against the ROS
generating properties of chemotherapeutics [10,12,13].
Autophagy (or self-eating) is a lysosome-mediated degradation pro-
cess for non-essential or damaged cellular constituents. It is amulti-step
process, involving the formation of double-membrane vesicles known
as autophagosomes. Elongation of the autophagosomal membrane en-
tails conjugation of MAP1-light chain 3 (LC3) protein to phosphatidyl-
ethanolamine to form a lipidated type of LC3 (LC3-II) [14], which is
often used as a marker of autophagy. Autophagosomes mature and
fuse with lysosomes to degrade their contents in the acidic environ-
ment mediated by acidic hydrolases. Physiologically, autophagy has
the role to preserve the balance between organelle biogenesis, protein
synthesis and their clearance. More recently, it has been shown that
autophagy is an important mediator of pathological responses and is
engaged in cross-talk with ROS in cell signaling and protein damage
[15].
Besides its conventional metabolic role, the glycolytic enzyme
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) participates
in diverse cellular functions, including autophagy [16]. An important
level of regulation is the translocation of the enzyme to the nucleus,
which can be triggered in response to oxidative stress [17]. Recently,
it has been demonstrated that, upon nuclear translocation, GAPDH
673I. Dando et al. / Biochimica et Biophysica Acta 1833 (2013) 672–679contributes to cell death [18], autophagy protein Atg12 up-regulation
and autophagy stimulation [19].
In the present study, we have investigated the regulation of
autophagy in response to over-expression or inhibition of UCP2 and
its role in pancreatic adenocarcinoma cell proliferation.
2. Materials and methods
2.1. Chemicals
Gemcitabine (2′,2′-diﬂuoro-2′-deoxycytidine; Jemta; GEM) was
provided by Sandoz Italia and was solubilized in sterile water. Genipin
(methyl-2-hydroxy-9-hydroxymethyl-3-oxabicyclonona-4,8-diene-5-
carboxylate) was obtained from Sigma (Milan, Italy), solubilized in
DMSO and stored at−80 °C until use. N-acetyl-L-cysteine (NAC), chlo-
roquine diphosphate (CQ), and 3-methyladenine (3-MA)were obtained
from Sigma.
2.2. Cell culture
Human pancreatic adenocarcinoma cell lines PaCa44, PaCa3, and
Panc1 were grown in RPMI 1640 supplemented with 2 mM gluta-
mine (Life Technologies, Milan, Italy), 10% FBS, and 50 μg/ml genta-
micin sulfate (BioWhittaker, Lonza, Bergamo, Italy). All cell lines
were incubated at 37 °C with 5% CO2.
2.3. Cell proliferation assay
Cells were seeded in 96-well plates (5×103 cells/well), 24 h later
treatedwith various compounds and further incubated for the indicated
times (see legends to ﬁgures). At the end of the treatments, cells were
stained with a Crystal Violet solution (Sigma, Milan, Italy). The dye
was solubilized in PBS containing 1% SDS andmeasured photometrical-
ly (A595nm) to determine cell growth. Three independent experiments
were performed for each assay condition.
2.4. Over-expression and silencing of UCP2
UCP2 over-expression experiments were performed using a pCMV
expression vector containing the human cDNA of UCP2 (OriGene Tech-
nologies, Rockville, MD) using TransIT-LT1 transfection reagent (Mirus,
Tema Ricerca, Bologna, Italy). Cells transfected with the empty pCMV
vector were used as a negative control (mock). Cells were incubated for
72 h to evaluate the effect of UCP2 over-expression on autophagosome
formation.
UCP2 silencing experiments were carried out with a speciﬁc small
interfering (si) (5′-GCUAAAGUCCGGUUACAGATT-3′) RNA targeting
UCP2 mRNA and a non-targeting (NT) siRNA (5′-CAGUCGCGUUU
GCGACUGG-3′) purchased by Ambion Life Technologies (Monza MB,
Italy). Cells were transfected with siRNAs at a ﬁnal concentration of
200 nM using Transfectin for 72 h (Biorad, Milan, Italy).
Transfection efﬁciency of PaCa44 cells was about 40% as previous-
ly assessed by cytoﬂuorimetric analysis using a pGFP plasmid vector.
2.5. Analysis of ROS
Thenon-ﬂuorescent diacetylated 2′,7′-dichloroﬂuorescein (DCF-DA)
probe (Sigma), which becomes highly ﬂuorescent upon oxidation, was
used to evaluate intracellular ROS production. Brieﬂy, cells were plated
in 96-well plates (5×103 cells/well) and, 24 h later, treated with vari-
ous compounds, as indicated in the legends to ﬁgures. Then, cells were
incubated with 10 μMDCF-DA for 15 min at 37 °C, and the DCF ﬂuores-
cencewasmeasured by using amultimode plate reader (Ex 485 nm and
Em535 nm). The valueswere normalized on cell proliferation by Crystal
Violet assay. Three independent experiments were performed for each
assay condition.2.6. Immunoblot analysis
To analyze GAPDH distribution nuclear and cytoplasmic protein
extracts were obtained with Nuclear Extract Kit (Active Motif),
electrophoresed through a 12% SDS-polyacrylamide gel, and electro-
blotted onto PVDF membranes (Millipore, Milan, Italy). To analyze
LC3 isoforms (LC3-I and LC3-II) and UCP2 whole cell protein extracts
were obtained with RIPA Buffer (50 mM Tris–HCl pH 7.5, 150 mM
NaCl, 1% Igepal CA-630, 0.5% Na-Doc, 0.1% SDS, 1 mM Na3VO4,
1 mM NaF, 2.5 mM EDTA, 1 mM PMSF, and 1× protease inhibitor
cocktail) followed by incubation on ice for 30 min. The lysate was
centrifuged at 500 ×g for 10 min at 4 °C and the supernatant was
electrophoresed through a 18% SDS-polyacrylamide gel and electro-
blotted onto PVDF membranes (Millipore, Milan, Italy). Membranes
were then incubated with blocking solution [5% low-fat milk in
TBST (100 mM Tris pH 7.5, 0.9% NaCl, 0.1% Tween 20)] for 1 h at
room temperature and probed overnight at 4 °C with a rabbit mono-
clonal anti-GAPDH (1:1000 in blocking solution) (Cell Signaling), rab-
bit monoclonal anti-LC3 (1:1000) (Cell Signaling), or goat polyclonal
anti-UCP2 (1:1000) (Abnova) antibodies. Horseradish peroxidase
conjugated anti-rabbit IgG (1:8000) (Upstate Biotechnology, Milan,
Italy) or anti-goat IgG (1:1000) (Santa Cruz Biotechnology) were
used to detect speciﬁc proteins. Immunodetection was carried out
using chemiluminescent substrates (Amersham Pharmacia Biotech,
Milan, Italy) and recorded using a HyperﬁlmECL (AmershamPharmacia
Biotech). The bands were scanned as digital peaks and the areas of the
peaks were calculated in arbitrary units using the public domain NIH
Image software (http://rsb.info.nih.gov/nih-image/). The value of
Ponceau S dye was used as a normalizing factor.
2.7. Immunoﬂuorescence analysis
Cells (1.6×104) were grown on coverslips and treated with vari-
ous compounds at the indicated concentrations for 16 h. Cells were
permeabilized with PBS solution containing 3% BSA and 0.3% Triton
X-100 at RT for 15 min and incubated with rabbit GAPDH-antibody
(1:100) at RT for 90 min and then incubated with Alexa Fluor 488
anti-rabbit IgG antibody (1:500) at RT for 60 min. To assess nuclear
morphology, cells were incubated with Hoechst at RT for 2 min. Fluo-
rescence was visualized using excitation/emission wavelengths of
488/520 nm (green) and 350/460 nm (blue) for GAPDH and Hoechst,
respectively. Cells were examined using TCS-SP5 Leica confocal mi-
croscope at 40× magniﬁcation.
2.8. Autophagosome formation assay
To quantify the induction of autophagy, cells were incubated with
the ﬂuorescent probe monodansylcadaverine (MDC; Sigma, Milan,
Italy). MDC is a selective marker for acidic vesicular organelles
(AVOs), such as autophagic vacuoles and especially autolysosomes.
Brieﬂy, cells were seeded in 96-well plates (5×103 cells/well) and
treated with the various compounds as indicated in the legend. At the
end of the treatments, cells were incubated in culture medium with
50 μM MDC at 37 °C for 15 min. After incubation, cells were washed
with Hanks buffer (20 mM Hepes pH 7.2, 10 mM glucose, 118 mM
NaCl, 4.6 mM KCl, and 1 mM CaCl2) and ﬂuorescence was measured
by using a multimode plate reader (Ex 340 nm and Em 535 nm)
(GENios Pro, Tecan, Milan, Italy). The values were normalized on cell
proliferation by Crystal Violet assay. Three independent experiments
were performed for each assay condition.
2.9. Apoptosis assay
Cells were seeded in 96-well plates (5×103 cells/well) and, the
day after, treated with the various compounds at the indicated con-
centrations for 24 h. At the end of the treatment, cells were ﬁxed
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then washed twice with PBS and stained with annexinV/FITC (Bender
MedSystem, Milan, Italy) in binding buffer (10 mM HEPES/NaOH
pH 7.4, 140 mM NaOH, and 2.5 mM CaCl2) for 10 min at room tem-
perature in the dark. Finally, cells were washed with binding buffer
solution and ﬂuorescence was measured by using a multimode plate
reader (Ex 485 nm and Em 535 nm) (GENios Pro, Tecan, Milan,
Italy). The values were normalized on cell proliferation by Crystal Vi-
olet assay. Three independent experiments were performed for each
assay condition.
2.10. RNA extraction and qPCR
Total RNA was extracted from 106 cells using TRIzol Reagent (Life
Technologies, Milan, Italy), and 1 μg of RNA was reverse transcribed
using ﬁrst-strand cDNA synthesis. Real-time quantiﬁcation was3.5
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Fig. 1. Effect of UCP2 inhibition on ROS production and cell growth. (A) PaCa44 cells were se
or NT siRNA for 72 h. The DCF ﬂuorescence intensity, corresponding to the level of ROS pro
UCP2 siRNA vs. CTRL or NT siRNA. (B) PaCa44 cells were seeded in 96-well plates, incubated
for further 24 or 48 h. The DCF ﬂuorescence intensity, corresponding to the level of ROS pr
genipin vs. genipin+NAC (24 h); (***) pb0.001 genipin vs. genipin+NAC (48 h). (C) Pa
200 nM UCP2 siRNA or NT siRNA for 72 h. Cell proliferation was determined using the Cr
or NT siRNA. (D) PaCa44 cells were seeded in 96-well plates, incubated overnight, pre-trea
48 h. Cell proliferation was determined using the Crystal Violet colorimetric assay. Statistic
means (±SD) of three independent experiments each performed in triplicate.performed in triplicate samples by SYBR Green detection chemistry
with Power SYBR Green PCR Master Mix (Applied Biosystems) on a
7000 SequenceDetection System. The primers usedwere:Hs_UCP2_1_SG
QuantiTect Primer Assay for the UCP2 gene and Hs_RRN18S_1_SG
QuantiTect Primer Assay (Qiagen, Milan, Italy) for 18S rRNA. The ampliﬁ-
cation conditions consisted in an initial step of 15 min at 95 °C to activate
HotStarTaq DNA polymerase and 45 cycles of denaturation at 94 °C for
15 s, annealing at 55 °C for 30 s, and extension at 72 °C for 30 s. Three in-
dependent experiments were performed for each assay condition.2.11. Statistical analysis
ANOVA (post hoc Bonferroni) analysis was performed by GraphPad
Prism 5 software. p valuesb0.05, 0.01, or 0.001 were indicated as (*),
(**), or (*** or ###), respectively.-
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eded in 96-well plates, incubated overnight, and transfected with 200 nM UCP2 siRNA
duction, was measured by a multimode plate reader. Statistical analysis: (***) pb0.001
overnight, pre-treated with 10 mM NAC for 1 h and then treated with 250 μM genipin
oduction, was measured by a multimode plate reader. Statistical analysis: (**) pb0.01
Ca44 cells were seeded in 96-well plates, incubated overnight, and transfected with
ystal Violet colorimetric assay. Statistical analysis: (***) pb0.001 UCP2 siRNA vs. CTRL
ted with 10 mM NAC for 1 h and then treated with 250 μM genipin for further 24 or
al analysis: (**) pb0.01 genipin vs. genipin+NAC. For all experiments, values are the
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3.1. UCP2 inhibition induces ROS-mediated pancreatic adenocarcinoma
cell growth inhibition
To evaluate the effect of UCP2 inhibition on intracellular ROS pro-
duction, we performed ROS assays on PaCa44 adenocarcinoma cells
treated with UCP2 siRNA or the speciﬁc UCP2 inhibitor genipin.
Fig. 1A and B shows that ROS production was enhanced by both
UCP2 silencing and genipin and that genipin-mediated ROS enhance-
ment was almost completely hampered by the radical scavenger NAC.
Cell proliferation assay demonstrated that UCP2 siRNA (Fig. 1C) or
genipin (Fig. 1D) inhibited PaCa44 cell growth and that, consistent
with Fig. 1B, genipin-mediated effect was signiﬁcantly reduced by
NAC at both 24 and 48 h (Fig. 1D). UCP2 mRNA and protein levels
after UCP2 siRNA or NT siRNA transfections were analyzed using
qRT-PCR (Supplementary Fig. 1A) and Western blot (Supplementary
Fig. 1C).3.2. UCP2 inhibition stimulates ROS-dependent nuclear translocation of
GAPDH
Since GAPDH is a redox-sensitive enzyme and oxidative stress can
stimulate its nuclear translocation, we analyzed cellular distribution
of GAPDH after treatment with genipin and/or NAC for 16 h. Fig. 2A
shows that GAPDH translocated into the nucleus of the cells after
UCP2 inhibition by genipin and that this effect was hampered byHoechst GAP
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Fig. 2. Effect of UCP2 inhibition on cellular distribution of GAPDH. (A) PaCa44 cells were pre
immunoreactivity (green) appeared within cell nuclei (blue labeled with Hoechst) only in c
periments. (B) Western blot analysis of GAPDH expression levels in PaCa44 cells pre-treate
cytoplasmic protein extracts were obtained as described in Material and methods. Ponceau S
levels in the nucleus and cytoplasm of the cells. The bands of Western blot analyses were sc
value of Ponceau S dye was used as a normalizing factor. Values are the means (±SD) of
genipin+NAC (for nuclear localization).NAC. To conﬁrm this result, we performed Western blot analyses
using nuclear or cytoplasmic protein extracts. Fig. 2B and C shows
that genipin strongly increased GAPDH expression level in the nucle-
ar fraction of the cells and that this event was totally inhibited by
NAC.3.3. UCP2 inhibition induces ROS-dependent autophagy
Since GAPDH nuclear translocation is a strictly autophagy-related
event, we performed autophagosome formation assay and Western
blot analysis of LC3 isoforms after modulation of UCP2. We demon-
strate that UCP2 over-expression reduced both endogenous ROS
(Fig. 3A) and constitutive autophagosome formation of about 40%,
while UCP2 silencing strongly enhanced autophagy (Fig. 3B). UCP2
mRNA and protein levels after pCMV-UCP2 or empty vector transfec-
tions were analyzed using qRT-PCR (Supplementary Fig. 1B) and
Western blot (Supplementary Fig. 1C). Fig. 3C and D show that the in-
duction of autophagosomes and of LC3-II/LC3-I ratio expression level
by genipin was inhibited by NAC, demonstrating that oxidative stress
is required to stimulate autophagy by UCP2 inhibition. To further in-
vestigate autophagy regulation by UCP2, we extended autophagy as-
says to two additional pancreatic adenocarcinoma cell lines (Panc1
and PaCa3). Data reported in Supplementary Fig. 2A and B show, re-
spectively, that autophagosomes formation is induced by UCP2
siRNA in a concentration-dependent manner in Panc1 cells and that
the expression level of LC3-II isoform was enhanced by genipin in
both PaCa3 and Panc1 cell lines. Fig. 3E shows the regulation of ROS,DH  Merge
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ing concentrations of genipin for 24 h. The trends of ROS induction and
of autophagosomes formation were very similar and inversely correlat-
ed to cell growth, suggesting an antiproliferative role of ROS-dependent
autophagy by UCP2 inhibition. Comparable results were obtained after
PaCa44 cell treatment with increasing concentrations of genipin for
48 h (Supplementary Fig. 3). To exclude unspeciﬁc or side effects of
genipin in cells [13], we evaluated cell growth, ROS, and autophagy in
PaCa44 cells after a long exposure (6 days) to increasing concentrationsE
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Fig. 3. Effect of UCP2 over-expression or inhibition on autophagy. (A) PaCa44 cells we
pCMV-UCP2 or empty pCMV vector (mock) for 72 h. The DCF ﬂuorescence intensity, corre
Statistical analysis: (**) pb0.01 UCP2 o.e. vs. CTRL or mock. (B) PaCa44 cells were seeded
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CTRL or NT siRNA. (B) PaCa44 cells were seeded in 96-well plates, incubated overnight, pr
24 or 48 h. Statistical analysis: (*) pb0.05 genipin vs. genipin+NAC (24 h); (***) pb0.001
lyzed using the incorporation of monodansylcadaverine (MDC) probe. Values are the means
were seeded in 100-mm diameter culture dishes, incubated overnight, pre-treated with 10
were used for Western blot analysis of the autophagic marker LC3. (D) Quantitative evaluatio
ed with increasing concentrations of genipin for 24 h.of genipin. We observed that as low as 25 μM genipin was sufﬁcient to
inhibit PaCa44 cell proliferation and to induce ROS and autophagy (Sup-
plementary Fig. 4).
3.4. Autophagy induced by UCP2 inhibition has an antiproliferative role
To further analyze the role of autophagy stimulation on cell prolif-
eration and apoptosis by UCP2 inhibition, we treated PaCa44 cells
with genipin and/or the autophagy inhibitors chloroquine (CQ) or500
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shows that both UCP2 siRNA and genipin induced pancreatic adeno-
carcinoma apoptotic cell death. In addition, Fig. 4B shows that
genipin-mediated apoptosis was strongly reduced in the presence of
CQ, 3-MA, or NAC. Consistently, Fig. 4C reports that PaCa44 cell growth
inhibition by genipin was signiﬁcantly attenuated by autophagy inhibi-
tors. Altogether, these data indicate that ROS-dependent autophagy in-
duced by UCP2 inhibition in pancreatic adenocarcinoma cells is an
event that favors apoptotic cell death.3.5. Genipin/gemcitabine combined treatment strongly enhances autophagy
To evaluate whether UCP2 inhibition can enhance autophagy in-
duced by gemcitabine, the standard chemotherapeutic drug for pan-
creatic adenocarcinoma, we performed autophagosome formation
assay in PaCa44 cells treated with genipin and/or gemcitabine for
24 and 48 h. Fig. 5 shows that genipin induced autophagy at a higher
extent than gemcitabine and that their combination signiﬁcantly po-
tentiates autophagy triggered by single treatments at both 24 and0
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[10]).4. Discussion
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cancer cells. It is well known that UCP2 is an antioxidant mitochondrial
protein whose inhibition induces oxidative stress favoring the forma-
tion of mitochondrial superoxide ions [6]. Here, we show that ROS in-
duction is required for nuclear translocation of the glycolytic enzyme
GAPDH and for autophagic cell death triggered by UCP2 inhibition.
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t colorimetric assay. Values are the means (±SD) of three independent experiments
nipin+3MA; (***) pb0.001 genipin vs. CTRL.
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Fig. 6.Model of autophagy induction by genipin. The molecular mechanisms identiﬁed
in this study are shown. See text for further details.
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Fig. 5. Effect of genipin and/or gemcitabine on autophagy. PaCa44 cells were seeded in
96-well plates, incubated overnight, and treated with 500 nM GEM and/or 250 μM
genipin for 24 and 48 h. Autophagosome formation assays were performed using the in-
corporation ofmonodansylcadaverine (MDC) probe. Values are themeans (±SD) of three
independent experiments each performed in triplicate. Statistical analysis: (***) pb0.001
GEM+genipin vs. GEM or genipin (24 h); (###) pb0.001 GEM+genipin vs. GEM or
genipin (48 h).
678 I. Dando et al. / Biochimica et Biophysica Acta 1833 (2013) 672–679GAPDH is a key redox-sensitive protein, the activity of which is largely
affected by covalent oxidative modiﬁcations at its highly reactive
Cys152 residue that stimulate nuclear translocation of the enzyme and
regulate the fate of the cell [16]. GAPDH translocation into the nuclei
can be decoded as an extreme effort of the cell tomaintain ROS produc-
tion into tolerable levels. Indeed, studies in Caenorhabditis elegans indi-
cated that redox regulation of GAPDH can counteract oxidative stress by
repressing the glycolytic pathway and consequently rerouting the met-
abolic ﬂux to maintain an optimal NADPH/NADP+ ratio through the
pentose phosphate pathway (PPP) [21]. Enzymes of the PPP are crucial
for maintaining the cytoplasmic NADPH concentration, which provides
the redoxpower for knownantioxidant systems [22]. Accordingly, it is re-
markable that under oxidative stress conditions the expression of a sub-
set of glycolytic proteins is repressed, while the expression of a few
enzymes involved in the PPP is induced [23]. Consistent with this ﬁnd-
ing, enhanced activity of the PPP has been observed in neonatal rat
cardiomyocytes and in human epithelial cells after oxidative stress
stimulation [24,25]. Intriguingly, Colell and colleagues indentiﬁed a
novel role for GAPDH in autophagy induction demonstrating that its nu-
clear translocation participates in the up-regulation of the autophagy
protein Atg12 and that enforced expression of Atg12 obviated the re-
quirement for nuclear GAPDH [19].
Since AMPK is a positive regulator of autophagy during energetic
crisis and a key enzyme involved in GAPDH nuclear translocation by
direct phosphorylation [26], while mTOR is a known inhibitor of
autophagy [27], we analyzed the active/phosphorylated form of
AMPK and p70S6K, a direct target of mTOR signaling, following
UCP2 inhibition by genipin. Surprisingly, we observed that genipin
inhibited AMPK phosphorylation and induced p70S6K phosphoryla-
tion (data not shown), thus excluding the involvement of AMPK in
nuclear translocation of GAPDH and autophagy stimulation by UCP2
inhibition. These observations further sustain the role of ROS in
GAPDH nuclear translocation and autophagy, and suggest the absence
of a catabolic autophagic mechanism driven by cellular energetic de-
fault. Although the identiﬁcation of the molecular mechanisms at the
basis of AMPK inhibition and mTOR activation needs further investi-
gations, one may speculate that the regulations of these enzymes
can be an extreme attempt of cancer cells to moderate an excessive
and citotoxic autophagy stimulation. Indeed, it is well described that
autophagy can act as a protective mechanism during a stressful epi-
sode helping cancer cells to maintain their survival in a setting of in-
creased metabolic demands or hypoxic microenvironment, or, if
prolonged, it can lead to cell death, named “autophagic cell death”
[28,29]. In the present study, we demonstrate that autophagy inducedby UCP2 inhibition encloses a cancer cell death feature. Indeed, the
addition of the autophagy inhibitors CQ or 3-MA or the antioxidant
NAC strongly reduced pancreatic adenocarcinoma apoptotic cell
death preserving cell survival.
Furthermore, we show that UCP2 inhibition enhanced autophagy
induced by gemcitabine, the standard chemotherapeutic drug for
pancreatic cancer. Recently, our group demonstrated that gemcitabine
is able to induce UCP2 mRNA and that targeted inhibition of UCP2 dra-
matically increases the sensitivity to gemcitabine of several cancer cell
types in a ROS-dependent mechanism [10]. Altogether these observa-
tions, added to the previous demonstration that autophagy by
gemcitabine is a cell death mechanism [30,31], suggest that UCP2
mRNA induction by gemcitabine is a protective mechanism of cancer
cells involved in the attenuation of autophagy and that the enhanced
autophagy induced by genipin/gemcitabine combined treatment has a
role in their antiproliferative synergism (described in [10]). The major
molecular events deduced from our data are reported in Fig. 6.
5. Conclusions
In the present study we have clearly demonstrated for the ﬁrst
time the involvement of UCP2 in the ROS-dependent autophagy reg-
ulation of cancer cells supporting the usage of UCP2 inhibitors in the
anti-tumoral strategy for pancreatic adenocarcinoma and bringing
new insights in the ﬁeld of mitochondrial uncoupling proteins.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.10.028.
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